# L_2023030EN.01003401.xml

| 2.2.2023 | EN | Official Journal of the European Union | L 30/34 |
| --- | --- | --- | --- |

2.2.2023

EN

Official Journal of the European Union

L 30/34

---

Corrigendum to Commission Implementing Regulation (EU) 2021/403 of 24 March 2021 laying down rules for the application of Regulations (EU) 2016/429 and (EU) 2017/625 of the European Parliament and of the Council as regards model animal health certificates and model animal health/official certificates, for the entry into the Union and movements between Member States of consignments of certain categories of terrestrial animals and germinal products thereof, official certification regarding such certificates and repealing Decision 2010/470/EU

(
  Official Journal of the European Union L 113 of 31 March 2021
  )

On page 201, in Annex I, Chapter 26, point II.2.7.1:

for:

| ‘
  (1) either | [II.2.7.1. | they have been kept for a period of at least 60 days prior to and during collection of the oocytes in a third country, territory or zone thereof free from infection with bluetongue virus (serotypes 1-24) where no case of infection with bluetongue virus (serotypes 1-24) has been confirmed during the last 24 months in the targeted animal population;]’, |
| --- | --- | --- |

‘
  (1) either

(1)

[II.2.7.1.

they have been kept for a period of at least 60 days prior to and during collection of the oocytes in a third country, territory or zone thereof free from infection with bluetongue virus (serotypes 1-24) where no case of infection with bluetongue virus (serotypes 1-24) has been confirmed during the last 24 months in the targeted animal population;]’,

read:

| ‘
  (1) either | [II.2.7.1. | they have been kept for a period of at least 60 days prior to and during collection of the oocytes in a Member State or zone thereof free from infection with bluetongue virus (serotypes 1-24) where no case of infection with bluetongue virus (serotypes 1-24) has been confirmed during the last 24 months in the targeted animal population;]’. |
| --- | --- | --- |

‘
  (1) either

(1)

[II.2.7.1.

they have been kept for a period of at least 60 days prior to and during collection of the oocytes in a Member State or zone thereof free from infection with bluetongue virus (serotypes 1-24) where no case of infection with bluetongue virus (serotypes 1-24) has been confirmed during the last 24 months in the targeted animal population;]’.

On page 202, in Annex I, Chapter 26, points II.2.7.2 and II.2.7.3:

for:

| ‘
  (1) and/or | [II.2.7.2. | they have been kept in a seasonally disease-free zone, during the seasonally disease-free period, for a period of at least 60 days prior to and during collection of the oocytes, in a third country, territory or zone thereof with an approved eradication programme against infection with bluetongue virus (serotypes 1-24);] |
| --- | --- | --- |

‘
  (1) and/or

(1)

[II.2.7.2.

they have been kept in a seasonally disease-free zone, during the seasonally disease-free period, for a period of at least 60 days prior to and during collection of the oocytes, in a third country, territory or zone thereof with an approved eradication programme against infection with bluetongue virus (serotypes 1-24);]

| (1) and/or | [II.2.7.3. | they have been kept in a seasonally disease-free zone, during the seasonally disease-free period, for a period of at least 60 days prior to and during collection of the oocytes, in a third country, territory or zone thereof where the competent authority of the place of origin of the consignment of oocytes(1)/ in vitro produced embryos(1) has obtained the prior written consent of the competent authority of the Member State of destination to the conditions for establishment of that seasonally disease-free zone and to accept the consignment of oocytes(1)/ in vitro produced embryos(1);]’, |
| --- | --- | --- |

(1) and/or

(1)

[II.2.7.3.

they have been kept in a seasonally disease-free zone, during the seasonally disease-free period, for a period of at least 60 days prior to and during collection of the oocytes, in a third country, territory or zone thereof where the competent authority of the place of origin of the consignment of oocytes(1)/ in vitro produced embryos(1) has obtained the prior written consent of the competent authority of the Member State of destination to the conditions for establishment of that seasonally disease-free zone and to accept the consignment of oocytes(1)/ in vitro produced embryos(1);]’,

(1)

in vitro

(1)

(1)

in vitro

(1)

read:

| ‘
  (1) and/or | [II.2.7.2. | they have been kept in a seasonally disease-free zone, during the seasonally disease-free period, for a period of at least 60 days prior to and during collection of the oocytes, in a Member State or zone thereof with an approved eradication programme against infection with bluetongue virus (serotypes 1-24);] |
| --- | --- | --- |

‘
  (1) and/or

(1)

[II.2.7.2.

they have been kept in a seasonally disease-free zone, during the seasonally disease-free period, for a period of at least 60 days prior to and during collection of the oocytes, in a Member State or zone thereof with an approved eradication programme against infection with bluetongue virus (serotypes 1-24);]

| (1) and/or | [II.2.7.3. | they have been kept in a seasonally disease-free zone, during the seasonally disease-free period, for a period of at least 60 days prior to and during collection of the oocytes, in a Member State or zone thereof where the competent authority of the place of origin of the consignment of oocytes(1)/in vitro produced embryos(1) has obtained the prior written consent of the competent authority of the Member State of destination to the conditions for establishment of that seasonally disease-free zone and to accept the consignment of oocytes(1)/in vitro produced embryos(1);]’. |
| --- | --- | --- |

(1) and/or

(1)

[II.2.7.3.

they have been kept in a seasonally disease-free zone, during the seasonally disease-free period, for a period of at least 60 days prior to and during collection of the oocytes, in a Member State or zone thereof where the competent authority of the place of origin of the consignment of oocytes(1)/in vitro produced embryos(1) has obtained the prior written consent of the competent authority of the Member State of destination to the conditions for establishment of that seasonally disease-free zone and to accept the consignment of oocytes(1)/in vitro produced embryos(1);]’.

(1)

in vitro

(1)

(1)

in vitro

(1)

On page 202, in Annex I, Chapter 26, point II.2.8.1:

for:

| ‘
  (1) either | [II.2.8.1. | they have been kept for a period of at least 60 days prior to and during collection of the oocytes in a third country, territory or zone thereof where EHDV 1-7 has not been reported for a period of at least the preceding 2 years within a radius of 150 km of the establishment;]’, |
| --- | --- | --- |

‘
  (1) either

(1)

[II.2.8.1.

they have been kept for a period of at least 60 days prior to and during collection of the oocytes in a third country, territory or zone thereof where EHDV 1-7 has not been reported for a period of at least the preceding 2 years within a radius of 150 km of the establishment;]’,

read:

| ‘
  (1) either | [II.2.8.1. | they have been kept for a period of at least 60 days prior to and during collection of the oocytes in a Member State or zone thereof where EHDV 1-7 has not been reported for a period of at least the preceding 2 years within a radius of 150 km of the establishment;]’. |
| --- | --- | --- |

‘
  (1) either

(1)

[II.2.8.1.

they have been kept for a period of at least 60 days prior to and during collection of the oocytes in a Member State or zone thereof where EHDV 1-7 has not been reported for a period of at least the preceding 2 years within a radius of 150 km of the establishment;]’.

On page 202, in Annex I, Chapter 26, point II.2.8.3:

for:

| ‘
  (1) and/or | [II.2.8.3. | were resident in the exporting country in which according to official findings the following serotypes of EHDV exist: ... and have been subjected with negative results in each case to the following tests carried out in an official laboratory:’, |
| --- | --- | --- |

‘
  (1) and/or

(1)

[II.2.8.3.

were resident in the exporting country in which according to official findings the following serotypes of EHDV exist: ... and have been subjected with negative results in each case to the following tests carried out in an official laboratory:’,

read:

| ‘
  (1) and/or | [II.2.8.3. | were resident in the Member State in which according to official findings the following serotypes of EHDV exist: ... and have been subjected with negative results in each case to the following tests carried out in an official laboratory:]’. |
| --- | --- | --- |

‘
  (1) and/or

(1)

[II.2.8.3.

were resident in the Member State in which according to official findings the following serotypes of EHDV exist: ... and have been subjected with negative results in each case to the following tests carried out in an official laboratory:]’.

---